ALNYLAM PHARMACEUTICALS, INCALNYLAM PHARMACEUTICALS, INCALNYLAM PHARMACEUTICALS, INC

ALNYLAM PHARMACEUTICALS, INC

No trades
See on Supercharts

ALNY fundamentals

ALNYLAM PHARMACEUTICALS, INC revenue breakdown overview

ALNYLAM PHARMACEUTICALS, INC revenue for the last year amounted to 31.05 B MXN, the most of which — 31.05 B MXN — came from its highest performing source at the moment, Ribonucleic Acid Interference Therapeutics, the year earlier bringing 20.23 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought ALNYLAM PHARMACEUTICALS, INC 21.67 B MXN, and the year before that — 12.01 B MXN.

By source
By country